SCHEMBL17341226

SCHEMBL17341226

c1ccc2c(c1)-c1cccc3c(-c4ccc(-n5c6ccccc6c6cc7ccccc7cc65)cc4)ccc-2c13

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.40
▸ ATM Q13315 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ TSHR P16473 3/20 0.40
▸ MAPK1 P28482 3/20 0.40
▸ HSD17B10 Q99714 3/20 0.40
▸ HPGD P15428 2/20 0.40
▸ CASP1 P29466 2/20 0.40
▸ HIF1A Q16665 2/20 0.40
▸ CRHBP P24387 1/20 0.34
▸ CRHR2 Q13324 1/20 0.34
▸ KEAP1 Q14145 1/20 0.34
▸ NFE2L2 Q16236 1/20 0.34
▸ TP53 P04637 1/20 0.33
▸ CASP7 P55210 1/20 0.33
▸ HDAC4 P56524 1/20 0.33
▸ ALK Q9UM73 1/20 0.32
▸ CA12 O43570 2/20 0.32
▸ CA1 P00915 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17341426 0.96 ALDH1A1 (0.42) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL17341666 0.91 L3MBTL1 (0.37) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL17341503 0.90 ALDH1A1 (0.42) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL17341486 0.90 ALDH1A1 (0.38) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL25208637 0.89 L3MBTL1 (0.50) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL31003063 0.89 L3MBTL1 (0.50) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL16483363 0.89 HASPIN (0.41) L3MBTL1ATMKDM4E
SCHEMBL16483348 0.89 HASPIN (0.41) L3MBTL1ATMKDM4E
SCHEMBL17341227 0.88 L3MBTL1 (0.39) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL16483145 0.88 L3MBTL1 (0.39) L3MBTL1ATMKDM4EALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150364692-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2015-12-17 — — US disclosed
US-20150364692-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2015-12-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150364692-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, EZH1, EPCAM L3MBTL1 1428/4885ATM 2870/4885KDM4E 2383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback